|
Volumn 350, Issue 8, 2004, Pages 751-754
|
Bone Loss after Cardiac Transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
BIOLOGICAL MARKER;
BISPHOSPHONIC ACID DERIVATIVE;
CALCINEURIN INHIBITOR;
CALCITRIOL;
CALCIUM;
COLLAGEN;
COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE;
COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE;
CYCLOSPORIN;
GLUCOCORTICOID;
IMMUNOSUPPRESSIVE AGENT;
LOOP DIURETIC AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PARATHYROID HORMONE;
PEPTIDE;
RAPAMYCIN;
VITAMIN D DERIVATIVE;
APOPTOSIS;
BLOOD;
BONE DENSITY;
BONE MASS;
BONE MINERAL;
BONE MINERALIZATION;
BONE REMODELING;
CALCIUM ABSORPTION;
CALCIUM URINE LEVEL;
CLINICAL TRIAL;
CORTICOSTEROID THERAPY;
DRUG EFFECT;
DRUG MEGADOSE;
ESTROGEN DEFICIENCY;
FRACTURE;
GONAD DYSFUNCTION;
HEART TRANSPLANTATION;
HIGH RISK POPULATION;
HUMAN;
KIDNEY FUNCTION;
NUTRITIONAL STATUS;
OSTEOBLAST;
OSTEOCLAST;
OSTEOLYSIS;
OSTEOPOROSIS;
PATHOPHYSIOLOGY;
PATIENT MOBILITY;
PATIENT MONITORING;
POSTMENOPAUSE;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
SURVIVAL RATE;
WEIGHT REDUCTION;
ALENDRONATE;
BIOLOGICAL MARKERS;
BONE DENSITY;
BONE RESORPTION;
CALCITRIOL;
COLLAGEN;
COLLAGEN TYPE I;
FRACTURES, BONE;
HEART TRANSPLANTATION;
HUMANS;
PARATHYROID HORMONE;
PEPTIDES;
POSTOPERATIVE COMPLICATIONS;
|
EID: 1142286392
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp038240 Document Type: Review |
Times cited : (14)
|
References (0)
|